DrugPatentWatch Database Preview
Testosterone - Generic Drug Details
What are the generic sources for testosterone and what is the scope of testosterone freedom to operate?
Testosterone
is the generic ingredient in eighteen branded drugs marketed by Allergan Sales Llc, Alza, Aytu Bioscience Inc, Abbvie, Endo Pharms, Actavis Labs Ut Inc, Perrigo Israel, Upsher-smith Labs, Auxilium Pharms Llc, Ani Pharms Inc, Par Pharm, Perrigo Uk Finco, Watson Labs, Auxilium Pharms Inc, Eli Lilly And Co, Cipla Ltd, Lupin Ltd, Pharmacia And Upjohn, Hikma Farmaceutica, Luitpold, Mylan Institutional, Paddock Llc, Sandoz Inc, Sun Pharm Inds Ltd, Watson Pharms Inc, West-ward Pharms Int, Nexus Pharms, Bel Mar, Elkins Sinn, Lilly, and Endo Pharms Inc, and is included in fifty-five NDAs. There are forty-one patents protecting this compound and six Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.There are sixty-seven drug master file entries for testosterone. Seventeen suppliers are listed for this compound. There is one tentative approval for this compound.
Summary for testosterone
| US Patents: | 41 |
| Tradenames: | 18 |
| Applicants: | 31 |
| NDAs: | 55 |
| Drug Master File Entries: | 67 |
| Suppliers / Packagers: | 17 |
| Bulk Api Vendors: | 58 |
| Clinical Trials: | 763 |
| Patent Applications: | 7,275 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for testosterone |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for testosterone |
| DailyMed Link: | testosterone at DailyMed |
Pharmacology for testosterone
| Ingredient-type | Androstanes |
| Drug Class | Androgen |
| Mechanism of Action | Androgen Receptor Agonists |
Medical Subject Heading (MeSH) Categories for testosterone
Synonyms for testosterone
| (+-)-8-iso-testosterone |
| (+-)-retrotestosterone |
| (+-)-testosterone |
| (+)-testosterone |
| (17?)-17-Hydroxyandrost-4-en-3-one |
| (17b)-17-hydroxy-androst-4-en-3-one |
| (17beta)-17-Hydroxyandrost-4-en-3-one |
| (1S,2R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-6-en-5-one |
| (1S,2R,10R,11S,14S,15S)-14-HYDROXY-2,15-DIMETHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-5-ONE |
| (8alpha,10alpha,13alpha,14beta,17alpha)-17-hydroxyandrost-4-en-3-one |
| (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one |
| (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
| (8R,9S,10R,13S,14S,17S)-17-Hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one |
| 003T654 |
| 1050678-68-6 |
| 13-iso-testosterone |
| 17-.beta.-Hydroxyandrost-4-en-3-one |
| 17-beta-Hydroxy-delta(sup 4)-androsten-3-one |
| 17-beta-Hydroxyandrost-4-en-3-one |
| 17-Hydroxy-(17-beta)-androst-4-en-3-one |
| 17-Hydroxy-(17beta)-androst-4-en-3-one |
| 17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one |
| 17-Hydroxy-4-androsten-3-one |
| 17-hydroxy-androst-4-en-3-one |
| 17-hydroxy-D4-androsten-3-one |
| 17-Hydroxyandrost-4-en-3-one, (17.beta.)- |
| 17.beta.-Hydroxy-.DELTA.4-androsten-3-one |
| 17.beta.-Testosterone |
| 17a-hydroxy-(13a)-androst-4-en-3-one |
| 17a-hydroxy-13a-androst-4-en-3-one |
| 17a-hydroxy-14b-androst-4-en-3-one |
| 17a-hydroxy-androst-4-en-3-one |
| 17b-hydroxy-(10a)-androst-4-en-3-one |
| 17b-hydroxy-(13a)-androst-4-en-3-one |
| 17b-hydroxy-(8a,10a)-androst-4-en-3-one |
| 17b-hydroxy-(8a)-androst-4-en-3-one |
| 17b-hydroxy-(9b,10a)-androst-4-en-3-one |
| 17b-hydroxy-(9b)-androst-4-en-3-one |
| 17b-hydroxy-13a-androst-4-en-3-one |
| 17b-hydroxy-4-androsten-3-one |
| 17b-hydroxy-8a-androst-4-en-3-one |
| 17b-Hydroxy-androst-4-en-3-on |
| 17b-hydroxy-androst-4-en-3-one |
| 17b-Hydroxy-D4-androsten-3-one |
| 17b-Hydroxyandrost-4-ene-3-one |
| 17b-Testosterone |
| 17beta-Hydroxy-3-oxo-4-androstene |
| 17beta-Hydroxy-4-androsten-3-one |
| 17beta-hydroxy-4-androsten-3one |
| 17beta-Hydroxy-delta(sup4)-androsten-3-one |
| 17beta-Hydroxyandrost-4-en-3-one |
| 17beta-Hydroxyandrost-4-ene-3-one |
| 17beta-testosterone |
| 1i37 |
| 3kdm |
| 3XMK78S47O |
| 4-androsten-17-ol-3-one |
| 4-Androsten-17.beta.-ol-3-one |
| 4-Androsten-17beta-ol-3-one |
| 4-Androsten-3-one-17.beta.-ol |
| 4-Androsten-3-one-17b-ol |
| 4-Androsten-3-one, 17b-hydroxy- |
| 4-androstene-17beta-ol-3-one |
| 58-22-0 |
| 7-beta-Hydroxyandrost-4-en-3-one |
| 8-iso-testosterone |
| 9b-testosterone |
| 9b,10a-testosterone |
| AA 2500 |
| AB00973630-03 |
| AC-14899 |
| AC1L1LM0 |
| AK405367 |
| AKOS015894897 |
| AN-23597 |
| Andro 100 |
| Androderm |
| Androderm (TN) |
| Androderm, Delatestryl |
| AndroGel |
| Androgel (TN) |
| Androgel 1.62% |
| Androgel 1% |
| Androlin |
| Andronaq |
| Andronate 100 |
| Andronate 200 |
| Andropatch |
| Andropository 200 |
| Androsorb |
| Androst-4-en-17b-ol-3-one |
| Androst-4-en-17beta-ol-3-one |
| Androst-4-en-3-on-17B-ol |
| Androst-4-en-3-one, 17-beta-hydroxy- |
| Androst-4-en-3-one, 17-hydroxy-, (17-beta)- |
| Androst-4-en-3-one, 17-hydroxy-, (17.beta.)- |
| Androst-4-en-3-one, 17-hydroxy-, (17b)- |
| Androst-4-en-3-one, 17-hydroxy-, (17beta)- |
| Androst-4-en-3-one, 17-hydroxy, (17.beta.)- |
| Androst-4-en-3-one, 17beta-hydroxy- |
| Androst-4-ene-17b-ol-3-one |
| Andrusol |
| Andryl 200 |
| Axiron |
| Axiron (TN) |
| B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E |
| BC208298 |
| BDBM8885 |
| beta testosterone |
| BIDD:ER0555 |
| BIM-0061761.0001 |
| Bio-0678 |
| Bio-T-Gel |
| BT000432 |
| C-18145 |
| C00535 |
| CAS-58-22-0 |
| CCG-101189 |
| CCRIS 574 |
| CDB 111C |
| CHEBI:17347 |
| CHEMBL386630 |
| CMC_13449 |
| COL 1621 |
| CompleoTRT |
| component of Di-Genik (Salt/Mix) |
| component of Di-Met (Salt/Mix) |
| component of Duogen (Salt/Mix) |
| component of Intrinsa (Salt/Mix) |
| component of Mal-O-Fem (Salt/Mix) |
| component of Tostrex (Salt/Mix) |
| CP 601B |
| CPD000058344 |
| Cristerona T |
| Cristerone T |
| CS-1415 |
| D00075 |
| D06XMU |
| D4-Androsten-17b-ol-3-one |
| DB00624 |
| delta(sup 4)-Androsten-17(beta)-ol-3-one |
| delta4-androsten-17b-ol-3-one |
| delta4-Androsten-17beta-ol-3-one |
| DSSTox_CID_2371 |
| DSSTox_GSID_22371 |
| DSSTox_RID_76563 |
| DTXSID8022371 |
| EINECS 200-370-5 |
| Epitestosteron |
| Epitope ID:135865 |
| Everone 200 |
| Fortesta |
| Geno-cristaux gremy |
| GTPL2858 |
| Halotensin |
| HMS2052N11 |
| HMS2272B03 |
| HMS2272P03 |
| Homosteron |
| Homosterone |
| HSDB 3398 |
| HY-15554A |
| Intrinsa |
| LibiGel |
| LMST02020002 |
| LS-148813 |
| Lumitestosteron |
| Malerone |
| Malestrone (amps) |
| Malogen in Oil |
| Malogen, aquaspension injection |
| MCULE-1294118086 |
| Mertestate |
| MLS000563091 |
| MLS001032098 |
| MLS001306401 |
| MLS001424262 |
| MLS002174283 |
| mpp10 |
| MUMGGOZAMZWBJJ-DYKIIFRCSA-N |
| Nasobol |
| NC00439 |
| NCGC00091018-01 |
| NCGC00258243-01 |
| Neo-Hombreol F |
| Neo-testis |
| Neotestis |
| NSC 9700 |
| Oreton |
| Oreton F |
| Oreton-F |
| Orquisteron |
| Perandren |
| Percutacrine androgenique |
| PL000185 |
| Primotest |
| Primoteston |
| Q-101251 |
| rac-17b-hydroxy-(13a)androst-4-en-3-one |
| rac-17b-hydroxy-(8a)-androst-4-en-3-one |
| rac-17b-hydroxy-(9b,10a)androst-4-en-3-one |
| rac-17b-hydroxy-androst-4-en-3-one |
| RB3046 |
| Relibra |
| RP29985 |
| S00309 |
| SC-15109 |
| Scheinpharm Testone-Cyp |
| SCHEMBL8452 |
| SMR000058344 |
| SMR001261453 |
| Striant |
| Striant (TN) |
| Sustanon |
| Sustanone |
| Sustason 250 |
| Synandrol F |
| T-Cypionate |
| Teslen |
| Testamone 100 |
| Testandrone |
| Testaqua |
| Testiculosterone |
| Testim |
| Testim (TN) |
| Testobase |
| Testoderm |
| Testoderm Tts |
| Testogel |
| Testoject-50 |
| Testolin |
| Testopel Pellets |
| Testopropon |
| Testosteroid |
| Testosteron |
| Testosterona |
| Testosterona [INN-Spanish] |
| Testosterone (JAN/USP) |
| Testosterone [Androgenic steroids, anabolic] |
| Testosterone [INN:BAN] |
| Testosterone [USP:INN:BAN] |
| Testosterone 1.0 mg/ml in Acetonitrile |
| Testosterone 100 microg/mL in Acetonitrile |
| Testosterone and its esters |
| Testosterone for impurity D identification, European Pharmacopoeia (EP) Reference Standard |
| Testosterone for system suitability, European Pharmacopoeia (EP) Reference Standard |
| Testosterone hydrate |
| Testosterone solution |
| Testosterone solution, 1.0 mg/mL in 1,2-dimethoxyethane, drug standard |
| Testosterone solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material |
| Testosterone, >=98% |
| Testosterone, 1 |
| Testosterone, cell culture tested |
| Testosterone, European Pharmacopoeia (EP) Reference Standard |
| Testosterone, purum, >=99.0% (HPLC) |
| Testosterone, VETRANAL(TM), analytical standard |
| Testosterone; 4-Androsten-17?-ol-3-one; 17?-Hydroxy-4-androsten-3-one |
| Testosteronum |
| Testosteronum [INN-Latin] |
| Testostosterone |
| Testoviron |
| Testoviron Schering |
| Testoviron T |
| Testred Cypionate 200 |
| Testrin-P.A |
| Testro AQ |
| Testrone |
| Testryl |
| Tostrelle |
| Tostrex |
| Tox21_200689 |
| trans-Testosterone |
| UNII-3XMK78S47O |
| Viatrel |
| Virilon IM |
| Virormone |
| Virosterone |
| W-5033 |
| ZINC118912393 |
US Patents and Regulatory Information for testosterone
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin Ltd | TESTOSTERONE | testosterone | SOLUTION, METERED;TRANSDERMAL | 208061-001 | Oct 23, 2017 | AT | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Abbvie | ANDROGEL | testosterone | GEL;TRANSDERMAL | 021015-002 | Feb 28, 2000 | AB1 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||
| Upsher-smith Labs | VOGELXO | testosterone | GEL;TRANSDERMAL | 204399-002 | Jun 4, 2014 | AB2 | RX | No | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for testosterone
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Allergan Sales Llc | ANDRODERM | testosterone | FILM, EXTENDED RELEASE;TRANSDERMAL | 020489-001 | Sep 29, 1995 | ➤ Sign Up | ➤ Sign Up |
| Alza | TESTODERM | testosterone | FILM, EXTENDED RELEASE;TRANSDERMAL | 019762-002 | Oct 12, 1993 | ➤ Sign Up | ➤ Sign Up |
| Alza | TESTODERM | testosterone | FILM, EXTENDED RELEASE;TRANSDERMAL | 019762-001 | Oct 12, 1993 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for testosterone
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Follow DrugPatentWatch: